AUTOIMMUNE
Clinical trials for AUTOIMMUNE explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE trials appear
Sign up with your email to follow new studies for AUTOIMMUNE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Steroid tapering showdown: quick stop vs. slow wean in inflammation patients
Disease control Recruiting nowThis study looks at whether people with inflammatory or autoimmune diseases can safely stop taking steroids (like prednisone) right away instead of slowly reducing the dose over 4 weeks. The goal is to see if stopping quickly leads to more hospital visits or adrenal crises. About…
Matched conditions: AUTOIMMUNE
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could CAR t-cells tame myasthenia gravis? early trial launches
Disease control Recruiting nowThis early-phase study tests a new treatment called anitocabtagene autoleucel (anito-cel) for people with generalized myasthenia gravis, a condition that causes muscle weakness. Anito-cel is a type of CAR T-cell therapy that targets BCMA, a protein on certain immune cells. The tr…
Matched conditions: AUTOIMMUNE
Phase: PHASE1 • Sponsor: Arcellx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New autoimmune drug JANX011 enters first human safety trial
Knowledge-focused Recruiting nowThis early-stage study tests the safety of a new drug called JANX011 in 60 healthy adults. Researchers will give a single dose and monitor for side effects. The goal is to gather initial safety data before testing in people with autoimmune diseases.
Matched conditions: AUTOIMMUNE
Phase: EARLY_PHASE1 • Sponsor: Janux Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC